Source: Richard Davies / ABC News
A Louisiana jury has ordered an international drug firm to pay one of the largest corporate fines in U.S. history. Takeda Pharmaceuticals, Japan’s biggest drug-maker, has been hit with $6 billion in punitive damages for hiding a possible link between a best-selling diabetes drug and a patient’s bladder cancer.
The fight is over Actos. Eli Lilly, which marketed the drug in the U.S. until 2006, was ordered to pay a $3 billion penalty. Takeda Senior Vice President Kenneth Greisman said the company disagrees with the verdict and plans an appeal.
The drug comes with warnings about serious side effects, including liver problems, broken bones and higher risk of bladder cancer. Both companies have been hit by hundreds of lawsuits from patients. Takeda’s share price dropped more than 7 percent today on Japan’s stock exchange.
To read this article in its entirety visit ABC News.